Methotrexate-induced epidermal necrosis: A case series of 24 patients

Ting Jui Chen, Wen Hung Chung, Chun Bing Chen, Rosaline Chung Yee Hui, Yu Huei Huang, Yueh Tsung Lu, Chang Wei Wang, Kuo Hsien Wang, Li Cheng Yang, Shuen Iu Hung

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Methotrexate-induced epidermal necrosis (MEN) is a rare but life-threatening cutaneous reaction that mimics Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Objectives: To investigate the clinicopathology, risk factors, and prognostic factors of MEN. Methods: We enrolled 24 patients with MEN and 150 controls and analyzed the demographics, pathology, and plasma concentrations of methotrexate (MTX). Results: Patients with MEN showed extensive skin necrosis (mean, 33.2% total body surface area) but no target lesions. The histopathology displayed keratinocyte dystrophy. Early signs of MEN included painful skin erosions, oral ulcers, and leukopenia/thrombocytopenia. Although 79.2% patients received leucovorin treatment, there was 16.7% mortality. Risk factors for MEN included older age (>60 years), chronic kidney disease, and high initial dosage of MTX without folic acid supplementation. Renal insufficiency delayed MTX clearance. Severe renal disease and leukopenia predicted poor prognosis in MEN, but none of the SCORe of Toxic Epidermal Necrosis criteria were associated with mortality of MEN. Limitations: The study was limited by the small sample size. Conclusion: MEN exhibited distinct clinicopathologic features from SJS/TEN. Recognition of the early signs and prognostic factors is important, because the rapid institution of leucovorin may be helpful. To reduce the risk of MEN, physicians should avoid prescribing MTX to high-risk patients and titrate the dosage slowly upward with folic acid supplementation.

Original languageEnglish
JournalJournal of the American Academy of Dermatology
DOIs
Publication statusAccepted/In press - 2017

Fingerprint

Methotrexate
Necrosis
Stevens-Johnson Syndrome
Leucovorin
Leukopenia
Folic Acid
Skin
Oral Ulcer
Mortality
Poisons
Body Surface Area
Chronic Renal Insufficiency
Keratinocytes
Thrombocytopenia
Sample Size
Renal Insufficiency
Demography
Pathology

Keywords

  • Cutaneous adverse reactions
  • Methotrexate
  • Skin necrosis

ASJC Scopus subject areas

  • Dermatology

Cite this

Chen, T. J., Chung, W. H., Chen, C. B., Hui, R. C. Y., Huang, Y. H., Lu, Y. T., ... Hung, S. I. (Accepted/In press). Methotrexate-induced epidermal necrosis: A case series of 24 patients. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2017.02.021

Methotrexate-induced epidermal necrosis : A case series of 24 patients. / Chen, Ting Jui; Chung, Wen Hung; Chen, Chun Bing; Hui, Rosaline Chung Yee; Huang, Yu Huei; Lu, Yueh Tsung; Wang, Chang Wei; Wang, Kuo Hsien; Yang, Li Cheng; Hung, Shuen Iu.

In: Journal of the American Academy of Dermatology, 2017.

Research output: Contribution to journalArticle

Chen, TJ, Chung, WH, Chen, CB, Hui, RCY, Huang, YH, Lu, YT, Wang, CW, Wang, KH, Yang, LC & Hung, SI 2017, 'Methotrexate-induced epidermal necrosis: A case series of 24 patients', Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2017.02.021
Chen, Ting Jui ; Chung, Wen Hung ; Chen, Chun Bing ; Hui, Rosaline Chung Yee ; Huang, Yu Huei ; Lu, Yueh Tsung ; Wang, Chang Wei ; Wang, Kuo Hsien ; Yang, Li Cheng ; Hung, Shuen Iu. / Methotrexate-induced epidermal necrosis : A case series of 24 patients. In: Journal of the American Academy of Dermatology. 2017.
@article{5802ffdaeacf4b29b16a4b4f5079fb07,
title = "Methotrexate-induced epidermal necrosis: A case series of 24 patients",
abstract = "Background: Methotrexate-induced epidermal necrosis (MEN) is a rare but life-threatening cutaneous reaction that mimics Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Objectives: To investigate the clinicopathology, risk factors, and prognostic factors of MEN. Methods: We enrolled 24 patients with MEN and 150 controls and analyzed the demographics, pathology, and plasma concentrations of methotrexate (MTX). Results: Patients with MEN showed extensive skin necrosis (mean, 33.2{\%} total body surface area) but no target lesions. The histopathology displayed keratinocyte dystrophy. Early signs of MEN included painful skin erosions, oral ulcers, and leukopenia/thrombocytopenia. Although 79.2{\%} patients received leucovorin treatment, there was 16.7{\%} mortality. Risk factors for MEN included older age (>60 years), chronic kidney disease, and high initial dosage of MTX without folic acid supplementation. Renal insufficiency delayed MTX clearance. Severe renal disease and leukopenia predicted poor prognosis in MEN, but none of the SCORe of Toxic Epidermal Necrosis criteria were associated with mortality of MEN. Limitations: The study was limited by the small sample size. Conclusion: MEN exhibited distinct clinicopathologic features from SJS/TEN. Recognition of the early signs and prognostic factors is important, because the rapid institution of leucovorin may be helpful. To reduce the risk of MEN, physicians should avoid prescribing MTX to high-risk patients and titrate the dosage slowly upward with folic acid supplementation.",
keywords = "Cutaneous adverse reactions, Methotrexate, Skin necrosis",
author = "Chen, {Ting Jui} and Chung, {Wen Hung} and Chen, {Chun Bing} and Hui, {Rosaline Chung Yee} and Huang, {Yu Huei} and Lu, {Yueh Tsung} and Wang, {Chang Wei} and Wang, {Kuo Hsien} and Yang, {Li Cheng} and Hung, {Shuen Iu}",
year = "2017",
doi = "10.1016/j.jaad.2017.02.021",
language = "English",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Methotrexate-induced epidermal necrosis

T2 - A case series of 24 patients

AU - Chen, Ting Jui

AU - Chung, Wen Hung

AU - Chen, Chun Bing

AU - Hui, Rosaline Chung Yee

AU - Huang, Yu Huei

AU - Lu, Yueh Tsung

AU - Wang, Chang Wei

AU - Wang, Kuo Hsien

AU - Yang, Li Cheng

AU - Hung, Shuen Iu

PY - 2017

Y1 - 2017

N2 - Background: Methotrexate-induced epidermal necrosis (MEN) is a rare but life-threatening cutaneous reaction that mimics Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Objectives: To investigate the clinicopathology, risk factors, and prognostic factors of MEN. Methods: We enrolled 24 patients with MEN and 150 controls and analyzed the demographics, pathology, and plasma concentrations of methotrexate (MTX). Results: Patients with MEN showed extensive skin necrosis (mean, 33.2% total body surface area) but no target lesions. The histopathology displayed keratinocyte dystrophy. Early signs of MEN included painful skin erosions, oral ulcers, and leukopenia/thrombocytopenia. Although 79.2% patients received leucovorin treatment, there was 16.7% mortality. Risk factors for MEN included older age (>60 years), chronic kidney disease, and high initial dosage of MTX without folic acid supplementation. Renal insufficiency delayed MTX clearance. Severe renal disease and leukopenia predicted poor prognosis in MEN, but none of the SCORe of Toxic Epidermal Necrosis criteria were associated with mortality of MEN. Limitations: The study was limited by the small sample size. Conclusion: MEN exhibited distinct clinicopathologic features from SJS/TEN. Recognition of the early signs and prognostic factors is important, because the rapid institution of leucovorin may be helpful. To reduce the risk of MEN, physicians should avoid prescribing MTX to high-risk patients and titrate the dosage slowly upward with folic acid supplementation.

AB - Background: Methotrexate-induced epidermal necrosis (MEN) is a rare but life-threatening cutaneous reaction that mimics Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Objectives: To investigate the clinicopathology, risk factors, and prognostic factors of MEN. Methods: We enrolled 24 patients with MEN and 150 controls and analyzed the demographics, pathology, and plasma concentrations of methotrexate (MTX). Results: Patients with MEN showed extensive skin necrosis (mean, 33.2% total body surface area) but no target lesions. The histopathology displayed keratinocyte dystrophy. Early signs of MEN included painful skin erosions, oral ulcers, and leukopenia/thrombocytopenia. Although 79.2% patients received leucovorin treatment, there was 16.7% mortality. Risk factors for MEN included older age (>60 years), chronic kidney disease, and high initial dosage of MTX without folic acid supplementation. Renal insufficiency delayed MTX clearance. Severe renal disease and leukopenia predicted poor prognosis in MEN, but none of the SCORe of Toxic Epidermal Necrosis criteria were associated with mortality of MEN. Limitations: The study was limited by the small sample size. Conclusion: MEN exhibited distinct clinicopathologic features from SJS/TEN. Recognition of the early signs and prognostic factors is important, because the rapid institution of leucovorin may be helpful. To reduce the risk of MEN, physicians should avoid prescribing MTX to high-risk patients and titrate the dosage slowly upward with folic acid supplementation.

KW - Cutaneous adverse reactions

KW - Methotrexate

KW - Skin necrosis

UR - http://www.scopus.com/inward/record.url?scp=85019074367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019074367&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2017.02.021

DO - 10.1016/j.jaad.2017.02.021

M3 - Article

C2 - 28499754

AN - SCOPUS:85019074367

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

ER -